Scott E. Millman
Memorial Sloan Kettering Cancer Center(US)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Cell death mechanisms and regulation, Cancer, Hypoxia, and Metabolism, Ubiquitin and proteasome pathways, Chronic Myeloid Leukemia Treatments
Most-Cited Works
- → Fbxw7α- and GSK3-mediated degradation of p100 is a pro-survival mechanism in multiple myeloma(2012)169 cited
- → Vitamin B6 Addiction in Acute Myeloid Leukemia(2020)98 cited
- → Metabolism in acute myeloid leukemia: mechanistic insights and therapeutic targets(2022)91 cited
- → MCL1 meets its end during mitotic arrest(2011)21 cited
- → Metabolic adaptations direct cell fate during tissue regeneration(2025)19 cited
- → Fbw7γ-mediated degradation of KLF13 prevents RANTES expression in resting human but not murine T lymphocytes(2012)17 cited
- → SCF-Mediated Degradation of p100 (NF-κB2): Mechanisms and Relevance in Multiple MyelomaA Presentation from the Sixth International Conference on SUMO, Ubiquitin and UBL proteins: Implications for Human Diseases, MD Anderson Cancer Center, Houston, Texas, 8 to 11 February 2012.(2012)14 cited
- → α-Ketoglutarate dehydrogenase is a therapeutic vulnerability in acute myeloid leukemia(2025)13 cited
- → Annotation of Somatic Genomic Variants in Hematologic Diseases Using OncoKB, a Precision Oncology Knowledgebase(2019)4 cited
- → Ogdh Is a Genetic Vulnerability and Therapeutic Target in Acute Myeloid Leukemia(2022)3 cited